
iGlobe Partners
Description
iGlobe Partners is a well-established venture capital firm headquartered in Singapore, with a significant presence in the global technology and biotech investment landscape. Founded in 1999, the firm has built a reputation for its distinctive cross-border investment strategy, actively bridging innovation ecosystems between Asia, the United States, and Europe. This approach allows iGlobe to identify and nurture high-potential startups that can leverage global markets and talent, fostering a diverse portfolio with international reach.
The firm primarily targets early-stage companies, typically from Seed to Series B rounds, with a keen interest in deep technology, enterprise software, artificial intelligence, cybersecurity, and biotechnology. iGlobe Partners manages a series of funds, demonstrating consistent capital deployment over two decades. Its most recent vehicle, iGlobe Platinum Fund VII, successfully closed at $100 million in 2021, underscoring its continued commitment to these strategic sectors and its ability to attract significant investor capital.
iGlobe's investment philosophy extends beyond capital provision, focusing on active strategic support and leveraging its extensive network to facilitate growth and market expansion for its portfolio companies. This hands-on approach has contributed to a strong track record of successful exits, including notable public listings such as Unity Technologies and NerdWallet, alongside successful acquisitions. The firm's long-standing experience and specialized sector expertise position it as a valuable partner for ambitious startups aiming for global impact and sustainable growth.
Investor Profile
iGlobe Partners has backed more than 35 startups, with 0 new investments in the last 12 months alone. The firm has led 5 rounds, about 14% of its total and boasts 13 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Seed rounds (top funding stages).
- Majority of deals are located in United States, Singapore, United Kingdom.
- Strong thematic focus on Biotechnology, Health Care, Cloud Computing.
- Typical check size: $1M – $5M.
Stage Focus
- Series B (34%)
- Series A (29%)
- Seed (17%)
- Series Unknown (9%)
- Series C (9%)
- Pre Seed (3%)
Country Focus
- United States (57%)
- Singapore (17%)
- United Kingdom (9%)
- China (9%)
- Israel (3%)
- Canada (3%)
- Denmark (3%)
Industry Focus
- Biotechnology
- Health Care
- Cloud Computing
- Manufacturing
- Financial Services
- Fintech
- Virtual Reality
- Semiconductor
- Mobile
- Video
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.